Limited Brands Q3
This article was originally published in The Rose Sheet
Executive Summary
Bath & Body Works sales grew 16.3% to $414.2 mil. for the third quarter (ended Oct. 28), driven by new fragrances in its signature collection and the introduction of holiday assortments, Limited Brands reports Nov. 16. All segments of the Victoria's Secret business performed well during the quarter, with overall sales increasing 19% to $987.9 mil., CEO and President Sharen Turney noted during a Nov. 15 call. Going forward, the brand will focus on holiday promotions and continue to invest in media, direct mail and special offers, she said. VS Beauty achieved strong sales growth with the launch of the Very Sexy makeup line and Dream Angels Desire fragrance. Separately, Limited Brands announces that it will acquire $628 mil. worth of outstanding shares of Canadian apparel firm La Senza...
You may also be interested in...
Ratio Therapeutics On BMS Investment, Radiopharma R&D Trends, AI Use
The CEO and CSO of radiopharmaceutical company Ratio Therapeutics, which now has Bristol Myers Squibb as an investor, talk about Ratio’s R&D platforms, use of AI, an independent FAP-targeted asset and trends in radiopharma research such as combining other modalities like ADCs, in this podcast interview with Scrip
With One Launch Under Way, SpringWorks Ramps Up For A Second
The company initiated a rolling submission with the US FDA for mirdametinib, a MEK inhibitor that is poised to be its second commercial product for a rare disease.
Finance Watch: Ten IPOs So Far In 2024, But Returns To Date Are Subpar
Public Company Edition: This year’s newly public companies are trading an average of 9.7% below their IPO prices, including the two most recent debuts, Boundless Bio and Contineum. Also, Nkarta, Praxis and Nurix grossed $240m, $200m and $175m, respectively, in follow-on offerings.